13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.
Also called NCT02492438
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 154 participants
- Sponsor
- Registry
-
NCT02492438
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium
- Registry status
- Completed
Technical summary
Registry record NCT02492438. Non-randomized; no masking; primary purpose prevention. Start 2013-02 (registry gives no type); primary completion 2014-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- 13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients
- Condition
- Chronic Kidney Failure
- Intervention (Biological)
- PPV23 vaccination or PCV13 vaccination
- Lead sponsor
- AZ Sint-Jan AV
- Collaborator
- Pfizer
Record details
- Record id
cardio:ct-nct02492438- Content hash
4dc51d79cf7637679275ca2adb0db0dde1e837dc456c0e464af3291d1d4e56f4